REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka N33 OOO (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Apteka N33 OOO Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Apteka N33 OOO is based in Russia, with the head office in Mikun. It operates in the Pharmacies and Drug Stores industry. The company was established on August 29, 2007. 1 (2023) employees currently work for Apteka N33 OOO. From the latest financial highlights, Apteka N33 OOO reported a net sales revenue increase of 22.4% in 2023. A negative growth of 7.16% was recorded in its total assets. The net profit margin of Apteka N33 OOO increased by 82.4% in 2023.

Headquarters
Mechnikova, 12
Mikun; Komi Republic; Postal Code: 169060

Contact Details: Purchase the Apteka N33 OOO report to view the information.

Basic Information
Total Employees:
Purchase the Apteka N33 OOO report to view the information.
Outstanding Shares:
Purchase the Apteka N33 OOO report to view the information.
Registered Capital:
Purchase the Apteka N33 OOO report to view the information.
Incorporation Date:
August 29, 2007
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Apteka N33 OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
22.4%
Total operating revenue
22.4%
Operating profit (EBIT)
36.19%
Net Profit (Loss) for the Period
36.19%
Total assets
-7.16%
Total equity
-7.16%
Operating Profit Margin (ROS)
82.4%
Net Profit Margin
82.4%
Return on Equity (ROE)
2.7%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?